Pradaxa Increases GI Bleeding But Not Heart Attack Risk, Medicare Data Show
This article was originally published in The Pink Sheet Daily
Executive Summary
Higher incidence of gastrointestinal bleeding among the Medicare population contrasts with findings from an earlier Mini-Sentinel study of dabigatran and bleeding, but FDA said the disparity in results may reflect the age differences in the populations examined.